Effects of fibroblast growth factor 21 on cell damage in vitro and atherosclerosis in vivo

Rational Design of a Fibroblast Growth Factor 21-Based Clinical Candidate, LY2405319

(2013) Alexei Kharitonenkov et al.   PLoS One

The Modified Selenenyl Amide, M-hydroxy Ebselen, Attenuates Diabetic Nephropathy and Diabetes-Associated Atherosclerosis in ApoE/GPx1 Double Knockout Mice

(2013) Sih Min Tan et al.   PLoS One

SUMO fusion system facilitates soluble expression and high production of bioactive human fibroblast growth factor 23 (FGF23)

(2012) Xiaoju Liu et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

FGF21 and the Second Coming of PPARγ

(2012) Li Qiang et al.   CELL

Endoplasmic Reticulum Stress in Cardiometabolic Disorders

(2012) Lale Ozcan   Current Atherosclerosis Reports

Long-Acting FGF21 Has Enhanced Efficacy in Diet-Induced Obese Mice and in Obese Rhesus Monkeys

(2012) Murielle M. Véniant et al.   ENDOCRINOLOGY

In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity

(2012) Emilia S. Olson et al.   Integrative Biology

Sanguinarine Induces Apoptosis of HT-29 Human Colon Cancer Cells via the Regulation of Bax/Bcl-2 Ratio and Caspase-9-Dependent Pathway

(2012) Jun Sik Lee et al.   INTERNATIONAL JOURNAL OF TOXICOLOGY

Large-scale expression, purification, and glucose uptake activity of recombinant human FGF21 in Escherichia coli

(2011) Minjing Zhang et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Challenges ahead in signal transduction: MAPK as an example

(2011) Christina Kiel et al.   CURRENT OPINION IN BIOTECHNOLOGY

Adiponectin and atherosclerosis risk factors in African hemodialysis patients: A population at low risk for atherosclerotic cardiovascular disease

(2011) Oluwatoyin C. Amira et al.   Hemodialysis International

High-level expression and purification of soluble recombinant FGF21 protein by SUMO fusion in Escherichia coli

(2010) Huiyan Wang et al.   BMC BIOTECHNOLOGY

FGF21 reloaded: challenges of a rapidly growing field

(2010) Alexei Kharitonenkov et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway

(2009) S Inoue et al.   CELL DEATH AND DIFFERENTIATION

Fibroblast Growth Factor 21 Controls Glycemia via Regulation of Hepatic Glucose Flux and Insulin Sensitivity

(2009) Eric D. Berglund et al.   ENDOCRINOLOGY

Fibroblast Growth Factor 21 Regulates Lipolysis in White Adipose Tissue But Is Not Required for Ketogenesis and Triglyceride Clearance in Liver

(2009) Yuhei Hotta et al.   ENDOCRINOLOGY

Scaling up anti-mycobacterial drug susceptibility testing services in India: It is high time

(2009) S Singh   Indian Journal of Medical Microbiology

Fibroblast Growth Factor 21 Corrects Obesity in Mice

(2008) Tamer Coskun et al.   ENDOCRINOLOGY

FGF21 is an Akt-regulated myokine

(2008) Yasuhiro Izumiya et al.   FEBS LETTERS

βKlotho Is Required for Fibroblast Growth Factor (FGF) 21 Signaling through FGF Receptor (FGFR) 1c and FGFR3c

(2008) Masashi Suzuki et al.   MOLECULAR ENDOCRINOLOGY

Adipose Fibroblast Growth Factor 21 Is Up-Regulated by Peroxisome Proliferator-Activated Receptor   and Altered Metabolic States

(2008) E. S. Muise et al.   MOLECULAR PHARMACOLOGY

Adipogenesis and WNT signalling

(2008) Constantinos Christodoulides et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM